Skip to main content
. 2011 Mar 18;45(4):851–857. doi: 10.1165/rcmb.2010-0455OC

Figure 5.

Figure 5.

BLT1 antagonist reduces AHR and airway inflammation 48 hours after secondary challenge. (A) RL was measured in sensitized and challenged mice 48 hours after secondary OVA provocation. *P < 0.05 compared with all other groups. (B) Cellular composition in BAL fluid. (C) BAL cytokine levels. (D) BAL chemokine levels. (E) H&E staining. (F) Lung cell composition. (G) Periodic acid-Schiff staining. *P < 0.05 compared with OVA/OVA/vehicle. n = 12 in each group. *P < 0.05 compared with OVA/OVA/vehicle.